{"id":20796,"date":"2026-06-03T08:12:10","date_gmt":"2026-06-03T08:12:10","guid":{"rendered":"https:\/\/akdenizolay.com.tr\/index.php\/2026\/06\/03\/kanser-tedavisinin-gelecegini-sekillendirecek\/"},"modified":"2026-06-03T08:12:11","modified_gmt":"2026-06-03T08:12:11","slug":"kanser-tedavisinin-gelecegini-sekillendirecek","status":"publish","type":"post","link":"https:\/\/akdenizolay.com.tr\/index.php\/2026\/06\/03\/kanser-tedavisinin-gelecegini-sekillendirecek\/","title":{"rendered":"Kanser Tedavisinin Gelece\u011fini \u015eekillendirecek"},"content":{"rendered":"

Ac\u0131badem \u00dcniversitesi T\u0131p Fak\u00fcltesi \u00f6\u011frencileri taraf\u0131ndan bu y\u0131l 9.\u2019su d\u00fczenlenen ALIS26\u2019n\u0131n, temas\u0131 \u201cOnkoloji Evreni\u201d oldu. Kanser alan\u0131nda yeni bilgilerin payla\u015f\u0131ld\u0131\u011f\u0131 kongrede, MIT\u2019den Do\u00e7. Dr. Canan Da\u011fdeviren, Fox Chase Cancer Center\u2019dan Prof. Dr. Lorenzo Galluzzi, MD Anderson Cancer Center\u2019dan Prof. Dr. James W. Welsh ve King\u2019s College London\u2019dan Prof. Dr. John Maher gibi ara\u015ft\u0131rmalar\u0131yla bilim d\u00fcnyas\u0131nda dikkat \u00e7eken bilim insanlar\u0131, g\u00fcncel \u00e7al\u0131\u015fmalar\u0131n\u0131 ve bilimsel \u00f6ng\u00f6r\u00fclerini payla\u015ft\u0131.<\/em><\/strong><\/p>\n

Ac\u0131badem \u00dcniversitesi T\u0131p Fak\u00fcltesi \u00f6\u011frencileri taraf\u0131ndan bu y\u0131l dokuzuncusu d\u00fczenlenen ALIS26 \u2013 Oncoverse: Horizons in Cancer Kongresi, d\u00fcnyan\u0131n \u00f6nde gelen bilim insanlar\u0131n\u0131 ve y\u00fczlerce t\u0131p \u00f6\u011frencisini \u0130stanbul\u2019da bir araya getirdi. T\u00fcrkiye\u2019nin en b\u00fcy\u00fck \u00f6\u011frenci organizasyonlu t\u0131p kongrelerinden biri olarak g\u00f6sterilen etkinlikte, kanser ara\u015ft\u0131rmalar\u0131ndaki son geli\u015fmeler, yeni nesil tedavi y\u00f6ntemleri ve gelece\u011fin onkoloji yakla\u015f\u0131mlar\u0131 ele al\u0131nd\u0131.<\/p>\n

May\u0131s ay\u0131nda Ac\u0131badem \u00dcniversitesi\u2019nde ger\u00e7ekle\u015ftirilen kongre, bu y\u0131l \u201conkoloji evreni\u201d temas\u0131yla d\u00fczenlendi. \u0130mm\u00fcnoterapi, yapay zeka destekli tan\u0131 sistemleri, mikrobiyom ara\u015ft\u0131rmalar\u0131, organoid teknolojileri, radyoterapi, CAR-T h\u00fccre tedavileri ve ki\u015fiselle\u015ftirilmi\u015f kanser tedavileri gibi ba\u015fl\u0131klar\u0131n \u00f6ne \u00e7\u0131kt\u0131\u011f\u0131 kongreye, T\u00fcrkiye\u2019nin yan\u0131 s\u0131ra farkl\u0131 \u00fclkelerden \u00f6\u011frenciler ve ara\u015ft\u0131rmac\u0131lar da yo\u011fun ilgi g\u00f6sterdi.<\/p>\n

MIT\u2019den Do\u00e7. Dr. Canan Da\u011fdeviren, Fox Chase Cancer Center\u2019dan Prof. Dr. Lorenzo Galluzzi, MD Anderson Cancer Center\u2019dan Prof. Dr. James W. Welsh ve King\u2019s College London\u2019dan Prof. Dr. John Maher\u2019in de aralar\u0131nda bulundu\u011fu \u00e7ok say\u0131da uluslararas\u0131 bilim insan\u0131, kongrede g\u00fcncel \u00e7al\u0131\u015fmalar\u0131n\u0131 ve bilimsel \u00f6ng\u00f6r\u00fclerini payla\u015ft\u0131.<\/p>\n

Ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerini \u201cak\u0131ll\u0131 sava\u015f\u00e7\u0131lara\u201d d\u00f6n\u00fc\u015ft\u00fcren \u00e7al\u0131\u015fmalar<\/strong><\/p>\n

Kongrenin dikkat \u00e7eken isimlerinden biri olan King\u2019s College London \u00f6\u011fretim \u00fcyesi Prof. Dr. John Maher, modern CAR-T h\u00fccre tedavilerinin geli\u015fiminde \u00f6nc\u00fc rol oynayan bilim insanlar\u0131 aras\u0131nda yer al\u0131yor. Yakla\u015f\u0131k 25 y\u0131ld\u0131r kanser imm\u00fcnoterapisi alan\u0131nda \u00e7al\u0131\u015fmalar y\u00fcr\u00fcten Prof. Dr. John Maher, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin genetik olarak yeniden programlanarak kanser h\u00fccrelerini hedef almas\u0131n\u0131 sa\u011flayan yenilik\u00e7i yakla\u015f\u0131mlar\u0131yla tan\u0131n\u0131yor.<\/p>\n

\u00d6zellikle CD28 temelli ikinci nesil CAR-T teknolojisinin geli\u015ftirilmesindeki \u00e7al\u0131\u015fmalar\u0131yla dikkat \u00e7eken Prof. Dr. John Maher\u2019in ara\u015ft\u0131rmalar\u0131, bug\u00fcn l\u00f6semi ve baz\u0131 kan kanserlerinde umut verici sonu\u00e7lar\u0131 olan tedavilerin temelini olu\u015fturuyor. Prof. Dr. John Maher ayr\u0131ca kurucu bilimsel direkt\u00f6rl\u00fc\u011f\u00fcn\u00fc y\u00fcr\u00fctt\u00fc\u011f\u00fc Leucid Bio arac\u0131l\u0131\u011f\u0131yla laboratuvar ortam\u0131nda geli\u015ftirilen teknolojilerin ger\u00e7ek hastalarda uygulanabilmesi i\u00e7in klinik \u00e7al\u0131\u015fmalara da \u00f6nc\u00fcl\u00fck ediyor. Prof. Dr. John Maher, \u201cKanser tedavisinde art\u0131k yaln\u0131zca t\u00fcm\u00f6r\u00fc hedef alan y\u00f6ntemlerden s\u00f6z etmiyoruz. Hastan\u0131n kendi ba\u011f\u0131\u015f\u0131kl\u0131k sistemini yeniden e\u011fiterek \u00e7ok daha g\u00fc\u00e7l\u00fc ve hassas tedaviler geli\u015ftirebiliyoruz. Klasik kemoterapiden farkl\u0131 olarak do\u011frudan ba\u011f\u0131\u015f\u0131kl\u0131k sistemini kansere kar\u015f\u0131 harekete ge\u00e7iriyoruz. Yeniden programlanan h\u00fccreler, kanser h\u00fccrelerini hedef alarak etkili sonu\u00e7lar sa\u011flayabiliyor\u201d diyor.<\/p>\n

Gelecekte akci\u011fer, meme, beyin, pankreas, prostat kanseri gibi bir\u00e7ok kanserde kullan\u0131lacak \u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/strong><\/p>\n

Prof. Dr. John Maher, CAR-T tedavisinin \u00f6zellikle baz\u0131 kan kanserlerinde son y\u0131llar\u0131n en dikkat \u00e7ekici ba\u015far\u0131 hikayelerinden biri oldu\u011funu belirterek, \u201cGe\u00e7mi\u015fte tedavi se\u00e7eneklerinin olduk\u00e7a s\u0131n\u0131rl\u0131 oldu\u011fu baz\u0131 l\u00f6semi ve lenfoma hastalar\u0131nda CAR-T uygulamalar\u0131yla uzun s\u00fcreli ve g\u00fc\u00e7l\u00fc yan\u0131tlar elde edilmeye ba\u015fland\u0131\u201d diyor. Prof. Dr. John Maher, bu y\u00f6ntemin ba\u011f\u0131\u015f\u0131kl\u0131k sistemini do\u011frudan t\u00fcm\u00f6re y\u00f6nlendirdi\u011fini vurgulayarak, bu teknolojinin her y\u0131l daha da geli\u015fti\u011fini belirtti. Prof. Dr. John Maher, \u201cBug\u00fcn yaln\u0131zca kan kanserlerinde de\u011fil, gelecekte akci\u011fer kanseri, meme kanseri, beyin t\u00fcm\u00f6rleri, pankreas kanseri, prostat kanseri, karaci\u011fer kanseri ve kolon kanseri gibi en yayg\u0131n kat\u0131 t\u00fcm\u00f6rlerde de\u00a0etkili olabilecek yeni nesil CAR-T yakla\u015f\u0131mlar\u0131 \u00fczerinde \u00e7al\u0131\u015f\u0131yoruz. Bu alan, ki\u015fiselle\u015ftirilmi\u015f kanser tedavilerinin en umut verici ba\u015fl\u0131klar\u0131ndan biri haline geldi\u201d diye konu\u015fuyor.\u00a0<\/p>\n

Radyoterapi art\u0131k yaln\u0131zca \u2018\u0131\u015f\u0131n tedavisi\u2019 de\u011fil<\/strong><\/p>\n

Kongrede \u00f6ne \u00e7\u0131kan bir di\u011fer isim ise MD Anderson Cancer Center\u2019dan Prof. Dr. James Welsh oldu. Torasik onkoloji, yani akci\u011fer kanseri, yemek borusu kanseri ve g\u00f6\u011f\u00fcs bo\u015flu\u011fu t\u00fcm\u00f6rleri gibi g\u00f6\u011f\u00fcs b\u00f6lgesi kanserleri\u00a0<\/strong>alan\u0131ndaki \u00e7al\u0131\u015fmalar\u0131yla uluslararas\u0131 d\u00fczeyde tan\u0131nan Prof. Dr. James Welsh, radyoterapi ile imm\u00fcnoterapiyi bir araya getirerek, kanser tedavisinin etkisini art\u0131rd\u0131\u011f\u0131 klinik yakla\u015f\u0131mlar\u0131n \u00f6nc\u00fc ara\u015ft\u0131rmac\u0131lar\u0131 aras\u0131nda g\u00f6steriliyor.<\/p>\n

Prof. Dr. James Welsh\u2019in \u00e7al\u0131\u015fmalar\u0131, radyoterapinin yaln\u0131zca t\u00fcm\u00f6r\u00fc k\u00fc\u00e7\u00fcltmekle kalmad\u0131\u011f\u0131n\u0131, ayn\u0131 zamanda ba\u011f\u0131\u015f\u0131kl\u0131k sistemini aktive ederek v\u00fccudun kansere kar\u015f\u0131 daha g\u00fc\u00e7l\u00fc bir yan\u0131t olu\u015fturmas\u0131na yard\u0131mc\u0131 olabilece\u011fini ortaya koyuyor. \u00d6zellikle akci\u011fer kanseri gibi tedavisi zor kanser t\u00fcrlerinde, radyoterapi ve imm\u00fcnoterapinin birlikte kullan\u0131m\u0131na y\u00f6nelik y\u00fcr\u00fctt\u00fc\u011f\u00fc klinik \u00e7al\u0131\u015fmalar bilim d\u00fcnyas\u0131nda geni\u015f yank\u0131 uyand\u0131rd\u0131.<\/p>\n

16 binden fazla bilimsel at\u0131fa sahip olan Prof. Dr. James Welsh, imm\u00fcno-radyoterapi alan\u0131n\u0131n klinik uygulamaya ta\u015f\u0131nmas\u0131nda etkili isimlerden biri olarak kabul ediliyor. Ara\u015ft\u0131rmalar\u0131 sayesinde bug\u00fcn doktorlar, her hastaya standart tedavi uygulamak yerine, t\u00fcm\u00f6r\u00fcn yap\u0131s\u0131na ve ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin \u00f6zelliklerine g\u00f6re daha ki\u015fiselle\u015ftirilmi\u015f tedavi planlar\u0131 olu\u015fturabiliyor.<\/p>\n

Prof. Dr. James Welsh, \u201cRadyoterapiyi art\u0131k yaln\u0131zca \u0131\u015f\u0131n tedavisi olarak de\u011ferlendirmiyoruz. Radyasyonun ba\u011f\u0131\u015f\u0131kl\u0131k sistemine \u2018kanser burada\u2019 sinyali verebildi\u011fini g\u00f6r\u00fcyoruz. Bu durum, imm\u00fcnoterapiyle birlikte kullan\u0131ld\u0131\u011f\u0131nda \u00e7ok daha etkili ve uzun s\u00fcreli sonu\u00e7lar sa\u011flayabiliyor\u201d diye konu\u015fuyor.\u00a0<\/p>\n

Gelecekte multidisipliner yakla\u015f\u0131mlar\u0131n daha da \u00f6nem kazanaca\u011f\u0131n\u0131 belirten Prof. Dr. James Welsh, \u201cKanser tedavisinin gelece\u011fi ki\u015fiselle\u015ftirilmi\u015f t\u0131pta yat\u0131yor. Her hastan\u0131n t\u00fcm\u00f6r biyolojisi farkl\u0131 ve tedavi stratejileri de buna g\u00f6re \u015fekillenmeli. Yapay zeka, imm\u00fcnoterapi ve radyoterapi kombinasyonlar\u0131 \u00f6n\u00fcm\u00fczdeki d\u00f6nemde onkolojinin y\u00f6n\u00fcn\u00fc belirleyecek\u201d ifadelerini kullan\u0131yor.\u00a0<\/p>\n

Gen\u00e7 doktor adaylar\u0131 d\u00fcnya bilim insanlar\u0131yla bulu\u015ftu<\/strong><\/p>\n

T\u00fcrkiye\u2019nin farkl\u0131 \u015fehirlerinden ve yak\u0131n co\u011frafyadaki uluslararas\u0131 t\u0131p fak\u00fcltelerinden \u00f6\u011frencilerin kat\u0131ld\u0131\u011f\u0131 kongrede d\u00fczenlenen bilimsel oturumlar, paneller ve interaktif sunumlar yo\u011fun ilgi g\u00f6rd\u00fc. Kat\u0131l\u0131mc\u0131lar, alan\u0131nda \u00f6nc\u00fc bilim insanlar\u0131yla birebir ileti\u015fim kurma ve kanser ara\u015ft\u0131rmalar\u0131ndaki g\u00fcncel geli\u015fmeleri yak\u0131ndan takip etme f\u0131rsat\u0131 buldu.<\/p>\n

ALIS26 Kongresi, yaln\u0131zca bilimsel i\u00e7erikleriyle de\u011fil, gen\u00e7 doktor adaylar\u0131n\u0131 d\u00fcnya \u00e7ap\u0131ndaki ara\u015ft\u0131rmac\u0131larla bulu\u015fturan yap\u0131s\u0131yla da dikkat \u00e7ekti. Organizasyon kapsam\u0131nda \u00f6\u011frenciler, gelece\u011fin onkoloji tedavilerine y\u00f6n veren \u00e7al\u0131\u015fmalar hakk\u0131nda kapsaml\u0131 bilgi edinirken, bilimsel ara\u015ft\u0131rmalar\u0131n klinik uygulamalara nas\u0131l d\u00f6n\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc de yak\u0131ndan g\u00f6zlemleme imkan\u0131 elde etti.<\/p>\n

\u00a0<\/p>\n

\u00a0<\/p>\n

Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"

Ac\u0131badem \u00dcniversitesi T\u0131p Fak\u00fcltesi \u00f6\u011frencileri taraf\u0131ndan bu y\u0131l 9.<\/p>\n","protected":false},"author":1,"featured_media":20797,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-20796","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/20796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=20796"}],"version-history":[{"count":1,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/20796\/revisions"}],"predecessor-version":[{"id":20798,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/20796\/revisions\/20798"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/media\/20797"}],"wp:attachment":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=20796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=20796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=20796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}